How many email patterns does ImmuneSensor Therapeutics use?

ImmuneSensor Therapeutics uses 1 known email pattern.

What domain does ImmuneSensor Therapeutics use for work emails?

ImmuneSensor Therapeutics uses immunesensor.com for work email addresses.

Most Common Email Formats at ImmuneSensor Therapeutics

ImmuneSensor Therapeutics's most common email format is FLast@immunesensor.com (ex. JDoe@immunesensor.com), used for 100% of immunesensor.com addresses. ImmuneSensor Therapeutics uses 1 email pattern.

@immunesensor.com

1 pattern

Format	Example	Share of immunesensor.com
FLast@immunesensor.comMost common	JDoe@immunesensor.com	100%

Need a specific person's email?

Browse ImmuneSensor Therapeutics's employee directory (about 9 employees) and reveal verified emails free.

Frequently Asked Questions

What does ImmuneSensor Therapeutics do?

ImmuneSensor Therapeutics operates in the Biotechnology Research industry, alongside similar companies like Innate Pharma, Johnson & Johnson and Merck. You can visit immunesensor.com. Explore ImmuneSensor Therapeutics's company overview page for more information.

What is ImmuneSensor Therapeutics's email address format?

ImmuneSensor Therapeutics's email format typically follows the pattern of FLast@immunesensor.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does ImmuneSensor Therapeutics have currently?

ImmuneSensor Therapeutics has approximately 9 employees as of November 2026. Key team members to contact include Co-Founder And Chairman: J. L., Vp, Research And Development: L. S. and Director Of Chemistry: J. Q. For more team information and contact data, explore ImmuneSensor Therapeutics's employee directory with LeadIQ.

ImmuneSensor Therapeutics Email Format

Biotechnology ResearchTexas, United States2-10 Employees

ImmuneSensor Therapeutics develops medicines that modulate the cGAS-STING axis of the innate immune system to treat cancer and autoimmune diseases. It licenses technologies from the University of Texas Southwestern Medical Center, specifically from Dr. Zhijian Chen’s laboratory, whose work identified cGAS and cGAMP as triggers of STING-driven immune responses. Its lead program, IMSA101, aims to activate STING and is in clinical development for cancer therapy, while additional candidates include a cGAS inhibitor designed to dampen overactive autoimmunity. 

Based in Dallas, Texas, the company operates with a small team focused on research and development in biotechnology. In May 2024, ImmuneSensor appointed Thomas W. Dubensky, Jr., Ph.D., as president and chief executive officer and as a member of the board.

Most common format

FLast@immunesensor.com

Example: JDoe@immunesensor.com

1 pattern. See all formats

Verify a ImmuneSensor Therapeutics email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at ImmuneSensor Therapeutics

@immunesensor.com

Need a specific person's email?

Frequently Asked Questions

What does ImmuneSensor Therapeutics do?

What is ImmuneSensor Therapeutics's email address format?

How many employees does ImmuneSensor Therapeutics have currently?

ImmuneSensor Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.